D-0659-2016 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0659-2016 was initiated by Sandoz Inc on Dec 31, 2015 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications; 9 month stability timepoint The recall status is terminated (terminated Apr 12, 2017). Affected quantity: 277,267 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 17, 2016
Initiation Date
Dec 31, 2015
Termination Date
Apr 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
277,267 bottles

Product description

Candesartan Cilexetil Tablets, 16 mg, a) 30 count (NDC 00781-5938-31) and b) 90 count (NDC 00781-5938-92) bottles, Rx Only, Manufactured by Mylan Laboratories Limited Hyderabad 500 034, India for Sandoz Inc. Princeton, NJ 08540

Reason for recall

Failed Impurities/Degradation Specifications; 9 month stability timepoint

Distribution pattern

Nationwide

Code information

a) 3022288 12/2015 3025988 03/2016 3025989 04/2016 3030459 08/2016 3030460 08/2016 3032087 10/2016 3032088 10/2016 3034506 12/2016 3035952 01/2017 3035953 01/2017 b) 3022287 12/2015 3025990 04/2016 3030458 08/2016 3032086 09/2016 3035954 01/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0659-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0659-2016. Report a data issue: hello@regdatalab.com.